Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC

Clinical trial NCT06138496 · COMPLETED

Trial details

NCT number: NCT06138496
Sponsor: Sun Yat-sen University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma

Start date: 2023-09-01
Primary completion: 2024-12-09
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.